A detailed history of Crown Wealth Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Crown Wealth Group, LLC holds 2,185 shares of ABT stock, worth $223,132. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,185
Previous 1,953 11.88%
Holding current value
$223,132
Previous $214,000 15.89%
% of portfolio
0.13%
Previous 0.13%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$109.52 - $120.96 $25,408 - $28,062
232 Added 11.88%
2,185 $248,000
Q4 2023

Jan 23, 2024

BUY
$90.19 - $110.4 $176,141 - $215,611
1,953 New
1,953 $214,000
Q2 2023

Jul 25, 2023

BUY
$100.78 - $112.29 $193,094 - $215,147
1,916 New
1,916 $208,000
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $196,964 - $231,069
2,072 New
2,072 $227,000
Q2 2022

Jul 25, 2022

SELL
$102.07 - $123.37 $15,922 - $19,245
-156 Reduced 6.97%
2,083 $226,000
Q1 2022

Jul 13, 2022

BUY
$114.02 - $139.04 $255,290 - $311,310
2,239 New
2,239 $265,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Crown Wealth Group, LLC Portfolio

Follow Crown Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crown Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crown Wealth Group, LLC with notifications on news.